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Abstract 
In this study the effect of recombinant human interleukin 2 (rec.hIL-2) on the proliferation 
and maturation of B lymphocytes was investigated. It was found that the presence of rec.hIL 2 
results in proliferation of mitogen (LPS)-activated B cell blasts. In addition, it is shown that 
highly enriched murine B cells can be induced by rec.hIL-2 to proliferate and to develop into 
antibody-secreting cells (PFC) in the presence of antigen (SRBC). When tested for its effect on 
B cell preparations enriched for resting (small) or activated (blasted) B lymphocytes, it was 
found that rec.hIL 2 provides signals for both B cell populations to develop into PFC. In 
contrast, induction of proliferation by the same lymphokine source was only seen in blasted 
B cells. The data indicate that IL 2 is involved in the generation of B effector cells by directly 
acting on their precursors thereby providing differentiation as well as proliferation signals. 
Introduction 
Interleukin 2 (IL 2) is well recognized as a proliferation factor for 
activated T lymphocytes (1), but there are indications that this lymphokine 
may also play a role in the growth and/or maturation of non-T cell 
populations (2, 3). In this respect, it is still a controversial issue whether 
IL 2 is capable of directly promoting the activation of B lymphocytes. In 
order to obtain more conclusive evidence, it is obligatory to use pure 
sources of IL 2 which do not contain additionallymphokine activities and a 
responder B cell population depleted of contaminating T cells. In this study 
we, therefore, compared the effect of re comb in ant human IL 2 (rec.hIL 2, 
Abbreviations: ConA = Concanavalin A; EL-4-SN = Supernatant of PMA-stimulated 
EL-4 tumor cells; IL 2 = interleukin 2; LPS = lipopolysaccharide; PPC = antibody-secreting 
cell; PMA = phorbol myristate acetate; rec.hIL-2 = human interleukin 2, expressed in E.coli 
by recombinant DNA techniques; SRBC = sheep red blood cells; TCGP = T cell growth 
factor(s) including interleukin 2; 3H-TdR = tritiated thymidine. 
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Sandoz Forschungsinstitut, Wien, Austria) with that of another lym-
phokine source, i.e. PMA-induced EL-4 thymoma supernatant (EL-4-SN), 
on the proliferation of B lymphocytes and the generation of antibody 
producing cells (PFC) from precursor B cells responding to sheep red blood 
cells (SRBC). The data demonstrate that IL 2 directly promotes the 
maturation of B lymphocytes. 
Materials and Methods 
Mice 
Mice of the strain C57Bli6 (B6) were obtained from the animal colony maintained at the 
Max-Planck-Institut fur Immunbiologie, Freiburg, FRG, and were used between 6 weeks and 
3 months of age. 
Cell separation techniques 
B cells were isolated from erythrocyte-free B6 spleen cell suspensions by treatment with 
anti-Thy-1.2 antiserum (Olac) and guinea pig complement (Behring), followed by another 
treatment with anti-Lyt-1.2 plus anti-Lyt-2.2 antisera and selected rabbit complement (4). 
B cells selected by this protocol completely lacked proliferative responses to Concanavalin A 
(ConA). This splenic B cell population was separated on the basis of size by Percoll 
(Pharmacia) density centrifugation to obtain the large (blasted) and the small (resting) B cell 
subsets (5). 
Cultures for proliferative and PFC responses 
All cultures were performed in Dulbecco's modified Eagle's medium (DMEM) sup-
plemented with 2 x 10-' M 2-mercaptoethanol, kanamycin (100 Ilg/ml), tylosine (10 Ilg/ml), 
glutamine (2 mM) and 10 % selected fetal calf serum. Cultures were set up in a total volume of 
200 J.tl in round bottom microtiter plates (Nunc, 163220, Wiesbaden, FRG) and were kept in a 
7 % COrincubator. For the detection of proliferative responses, 1 X 10' B cells/well were 
cultured for 3 days in the presence or absence of lymphokine sources and 1.25 IlCi tritiated 
thymidine eH -T dR) per well was added for the last 4 h. Cells were harvested onto filter strips 
using an automatic cell harvester and counted in a liquid scintillation ~-counter. For the 
detection of PFC responses, 3 x 10' B cells/well and 5 x 10' SRBC/well were cultured in the 
presence or absence of lymphokine sources. After 5 days of incubation, cultures were tested 
for direct SRBC-specific PFC as described (6). 
Mitogen-induced lymphoblasts were generated by incubating either 12 X 106 enriched 
B cells in 6 ml with 10 Ilg LPS/ml for 72 h or 12 x 106 nylon wool-purified T cells/6 ml with 
5 Ilg ConA/ml for 48 h. For the detection of proliferative responses, 6 X 104 mitogen-activated 
cells/well were cultured for 2 days in the presence or absence of lymphokine sources and 
3H-TdR was added for the last 4h. 
Lymphokine sources 
a) EL-4 supernatant (EL-4-SN) was obtained by stimulating a cloned subline of EL-4 
thymoma with 10 ng/ml phorbol myristate acetate (PMA) as described elsewhere (7). 
b) recombinant human interleukin 2 (rec.hIL 2) was kindly provided by Dr. M. WRANN, 
Sandoz Forschungsinstitut, Wien, Austria. 
The lymphokine sources were tested for their TCGF activity by incubating serial dilutions 
(50-0.02 ng rec.hIL 2, 50-0.38 % EL-4-SN) with 2 x 103 cells of the lymphokine-dependent 
cytotoxic T cell line CTLL 2 (kindly provided by Dr. GILLES) in a total volume of 200 III in 
round bottom microtiter plates. After 20 h of incubation, 1.25 IlCi 3H -T dR/well was added for 
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the last 4 h. Cells were harvested onto filter strips using an automatic cell harvester and 
counted in a liquid scintillation ~-counter. The data were subjected to probit analysis (8), and 
the activity was expressed in units of TCGF (1 U = 100 pg rec.hIL 2/0.2 ml, which allow half 
maximal proliferation of 2 x 103 CTLL-2 after 24h). 
Absorption of lymphokines 
IL 2 depletion of lymphokine sources was performed by incubating 2 x 107 CTLL-2 cells 
with either rec.hIL 2 or EL-4-SN (containing the amount of 1000 U IL-2) for 4-6 hours. The 
absorbed supernatants were collected after pelleting the cells and were functionally compared 
to the untreated samples on the basis of their original IL 2 content. When retested on CTLL-2, 
both absorbed lymphokine sources lacked detectable IL 2 activity. 
Results and Discussion 
Proliferation of B cells was measured by 3H -T dR incorporation, and 
differentiation into immunoglobulin-secreting cells was determined by 
testing for SRBC-specific plaque-forming cell responses (PFC). A 
thoroughly enriched B cell population was obtained by treating erythro-
cyte-free spleen cells with T cell-specific antisera and complement as 
described in Materials and Methods. In order to estimate the residual 
portion of functional T cells, we tested the selected B cell population for 
proliferative responses to the T cell-specific mitogen ConA. It could be 
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Fig. 1. Responsiveness of mitogen-induced T or B lymphoblasts to either rec.hIL 2 or EL-4-SN. 
Graded amounts of lymphokine sources were titrated into cultures containing either ConA-
activated T cells (e) or LPS-activated B cells (0). The proliferative responses were determined 
after an incubation period of 48 h as described in Materials and Methods. 
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demonstrated that the T cell-deprived B lymphocyte population completely 
lacked reactivity to ConA. Since mitogen-induced proliferation in these 
cultures was significantly enhanced only upon addition of 0.5 % nylon 
wool-purified T cells, we estimated the amount of contaminating T cells in 
the B cell population studied to be below this threshold (data not shown). 
To examine whether IL 2 induces proliferative responses in polyclonally 
activated T and B cell populations, graded amounts of lymphokines 
(rec.hIL 2 or EL-4-SN) were titrated into cultures containing either nylon 
wool-purified T cells which had been preactivated with ConA or selected 
B cells which had been preactivated with LPS (Fig. 1). The data clearly 
demonstrate that B lymphoblasts proliferated dose-dependently in response 
to rec.hIL 2, though to a somewhat lower degree when compared to 
T lymphoblasts. Similar dose response curves for proliferation were 
obtained for T cell blasts responding to either rec.hIL 2 or EL-4-SN. On 
the contrary, the growth of B cell blasts was inhibited at higher concentra-
tions of EL-4-SN which may be due to non-IL 2 components present in 
this factor source (see below). 
We next asked whether IL 2 is also involved in the generation of immune 
responses from antigen-activated B lymphocytes. For this purpose, the 
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Fig. 2. Effect of rec.hIL 2 and EL-4-SN on the proliferation and differentiation of either 
unfractionated B cell or of small or large B lymphocytes. For the detection of SRBC-specific 
antibody production, enriched T cell depleted B cells and SRBC were incubated in graded 
concentrations of lymphokine sources (rec.hIL 2, EL-4-SN) which had been adjusted to 
contain the same amount of IL 2 (as described in Materials and Methods). The cultures were 
tested for direct SRBC-specific PFC on day 5. For the detection of proliferative responses, B 
cells and graded amounts of lymphokine sources were incubated in the absence of SRBC and 
3H_ TdR incorporation was measured on day 3. The first lines of Exp. 1 and Exp. 2 show the 
responsiveness of control cultures lacking external factor sources. 
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appropriate B cell populations - either unfractionated or previously sepa-
rated for small (resting) and large (activated) B lymphocytes on a Percoll 
density gradient (5) - were incubated with graded amounts of lymphokine 
sources which had been adjusted to comparable IL 2 concentrations (arbi-
trary units, as described in Materials and Methods; Fig. 2). SRBC were 
included in the cultures for PFC generation but not in those for prolifera-
tive responses (see below). In the presence of both rec.hIL 2 and EL-4-SN, 
unseparated B cells showed significant antigen-independent proliferation 
and SRBC-specific PFC responses the level of which corresponded with the 
concentration of IL 2 in culture. In contrast, only marginal immune 
reactivities were observed in control cultures lacking external factors (Fig. 2, 
Exp. 1). When populations enriched for either B cell blasts or small B cells 
were tested separately under similar conditions, comparable PFC numbers 
were seen in both populations in response to either rec.hIL 2 or EL-4-SN 
(Fig. 2, Exp.2). In contrast, proliferation was only induced in B cell blasts 
but not in small B cells by the addition of either rec.hIL 2 or EL-4-SN, 
respectively. It is important to emphasize that the lymphokine-driven 
proliferative responses of both selected B cell populations were not altered 
by the addition of antigen (SRBC) to the cultures (data not shown). The 
data, therefore, reveal that rec.hIL 2 is capable of providing signals for the 
generation of PFC from both small and large B cells and, in addition, 
triggers B cell blasts but not small B cells for proliferation. The finding that 
IL 2 cannot induce replication of small, resting B cells even in the presence 
of antigen but drives them to maturation into PFC is similar to that 
described by MELCHERS et al. (9) for a T helper cell-derived B cell 
replication and maturation factor(s). In this study, it was shown that the 
factor-induced antibody production in small B cells was accompanied by a 
loss of their capacity to replicate. 
It should be noted that the E.coli-derived rec.hIL 2 preparation used in 
this study contains a minute amount of bacterial lipopolysaccharide (0.27 
ng LPS/mg IL-2 as determined in the limulus assay by Sandoz, Wien). Since 
the optimal LPS quantities required for a polyclonal B cell activation are 
some orders of magnitude higher, it is very unlikely that these traces of LPS 
have a perceptible effect. 
It was previously demonstrated that EL-4-SN in addition to IL 2 
contains other lymphokine(s) which can deliver activation signals to B 
lymphocytes (10). It was, therefore, of interest to test whether depletion of 
IL 2 from rec.hIL 2 and EL-4-SN would abrogate the capacity to activate B 
cells only in the former but not in the latter lymphokine source. We took 
advantage of the fact that the IL 2-dependent T cell line CTLL-2 preferen-
tially absorb IL 2 but not unrelated lymphokines by virtue of their specific 
cell surface receptor (8). Either unabsorbed or IL 2 depleted samples of 
EL-4-SN and rec.hIL 2 were added to unfractionated B cell cultures set up 
for proliferative and PFC responses (Fig. 3). As expected, the absorption of 
IL 2 from rec.hIL 2 sources significantly reduced the effects associated with 
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Fig. 3. Effect of either unabsorbed or IL 2-depleted samples of rec.hIL 2 and EL-4-SN on the 
proliferation and antibody formation of unselected B cells. The concentrations of the lym-
phokine sources (rec.hIL 2, EL-4-SN) to be absorbed with CTLL-2 were adjusted to contain 
the same amount of IL 2 as the untreated samples (as described in Materials and Methods). 
After depletion of IL 2, both lymphokine sources were titrated to cultures of unselected 
B cells. In addition, SRBC were included in the cultures for PFC responses_ Proliferation and 
PFC responses were tested as described in the legend to Fig. 1. The first line shows the 
responsiveness of control cultures lacking external factor sources. 
B cell activation (growth and PFC formation). In contrast, removal of IL 2 
from EL-4-SN had only marginal effects on its capability to induce B cell 
growth and differentiation. These results again emphasize the role of IL 2 in 
the induction of B cells and indicates the presence of additional B cell 
growth/maturation factor(s) in EL-4-SN which have been described before 
to provide triggering signals in humoral immune responses (10). In addi-
tion, the lack of activities in IL 2 depleted samples of rec.hIL 2 argues 
against the stimulatory effect being mediated by contaminating irrelevant 
proteins within the preparation used. This is also substantiated by the 
finding that a mock-IL 2 preparation had no effect on the generation of 
B cell responses (EMMRICH, unpublished results). 
The results given here demonstrate that murine B lymphocytes presen-
sitized in vitro by either mitogen or antigen as well as in vivo derived 
enriched B cell blasts are responsive to rec.hIL 2 which is in line with a 
recent study by ZUBLER et al. (11). Similar results have recently been 
obtained by our group (12) and others (11, 13) also in the human system 
showing that the same source of recombinant hIL 2 (11, 12) or a sample of 
affinity purified IL 2 (13) can induce proliferation and immunoglobulin 
secretion in polyclonal preactivated T cell-deprived B cell populations. This 
indicates that in the presence of antigen or mitogen the lymphokine signal 
provided by IL 2 is sufficient for the development of B effector cells from 
their precursors. Similar effects on the activation of B lymphocytes have 
been described before for T cell-derived soluble mediators distinct from IL 
2 (10). The combined data, therefore, suggest the existence of distinct 
lymphokines with the properties of growth and maturation factors for B 
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cells. However, the question whether they act on the same or different B 
lymphocyte subsets remains to be answered. In addition, the mode of 
action of IL 2 on the individual target cell in both small and large B cell 
populations is uncertain, but the fact that IL 2 can induce PFC responses in 
both populations and proliferation in the activated lymphocyte subset 
indicates that the same lymphokine can provide both growth and differenti-
ation signals. Because of the lack of an appropriate monoclonal antibody we 
could not yet demonstrate the expression of IL 2 receptor molecules on the 
B cell populations directly. However, we (12) and others (13) have recently 
shown in the human system that the monoclonal antibody anti-Tac (14) 
with specificity for the IL 2 receptor on T cells also stained activated B cells. 
This was indicated before for rat B lymphoblasts which were stained by a 
putative mouse anti-rat-IL 2 receptor antibody (15), and has now also been 
confirmed for murine B cells by ZUBLER et al. using a rat anti-mouse 
monoclonal antibody with similar specificity for the IL 2 receptor (11, and 
personal communication). The combined data, therefore, allow the conclu-
sion that IL 2 provides one of the essential signals to the B cell during 
development of humoral immune responses. 
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